Global Artificial Intelligence in Drug Discovery Market: Emerging Trends, Major Key Players Microsoft Corporation and IBM Corporation

According to the report, Artificial Intelligence in Drug Discovery Market is expected to hold a value of about USD 2,015.1 Million by 2025, and it is projected to register a CAGR of 41% from 2019 to 2025.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007428

The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY industry including a look at the current market size and forecasts for key segments and regions, the driving forces behind the market, the probable effects from key trends, how all these will affect the business plan, SWOT analysis of critical sectors for each of the key competitors, customers and more! Providing valuable data about conglomerations that are most likely going to have an impact on this industry is essential to any company who plans to properly invest for next 5 years. These findings supplement our initial quantitative study in order to facilitate any new investments or planning traits against threats in existing sectors through a strategic business plan.

Impact of COVID-19

The on-going COVID-19 pandemic has had a significant impact on the industry. Several financial impacts and disruptions have been felt over a long period of time. Our research has interviewed numerous delegates from this industry, across geographical markets to collect information that is helpful for addressing potential challenges the COVID-19 pandemic may cause going forward.
In terms of COVID 19 impact, the Artificial Intelligence in Drug Discovery market report also includes the following data points:
• Impact of COVID-19
• Government Aids and Policies for Industry Revival
• Companies Recent Developments to Tackle Negative Impact
• Opportunity Window & Post COVID Trend

For Any Query or Customization, Ask Our Industry Experts@ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007428

Key Players
Some of the major Artificial Intelligence in Drug Discovery players holding highest market share include Microsoft Corporation, IBM Corporation, Google (A Subsidiary of Alphabet Inc.), Atomwise, Inc.. These players use new product development as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
• Microsoft Corporation
• IBM Corporation
• Google (A Subsidiary of Alphabet Inc.)
• Atomwise, Inc.
• Deep Genomics
• Cloud Pharmaceuticals, Inc.
• Insilico Medicine
• BenevolentAI
• Exscientia
• Cyclica
• Bioage
• Numerate
• Numedii, Inc.
• Envisagenics
• Twoxar, Incorporated
• Owkin, Inc.
• Xtalpi, Inc.
• Verge Genomics
• Berg LLC

Segmental Analysis

Market Segment By Product Type with focus on market share, consumption trend, and growth rate of ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY Market:
• Software
• Services

Market Segment By Molecule Type with focus on market share, consumption trend, and growth rate of ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY Market:
• Large Molecule
• Small Molecule

Market Segment By Technology with focus on market share, consumption trend, and growth rate of ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY Market:
• Machine Learning
• Deep Learning
• others

Market Segment By Indication with focus on market share, consumption trend, and growth rate of ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY Market:
• Immune-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• others

Market Segment By Application with focus on market share, consumption trend, and growth rate of ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY Market:
• Target Identification
• Candidate Screening
• De novo Drug Designing
• Drug Optimization
• Repurposing
• Preclinical Testing

For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007428

Global Artificial Intelligence in Drug Discovery Geographic Coverage:
• North America
o US
o Canada

• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe

• Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Rest of Asia Pacific

• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of MEA

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India

Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.

Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.